Altimmune (ALT) Reports First Patient Dosing in Phase 1b Clinical Trial of NasoShield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil slips from five-month highs with Hormuz crossings, Russian sanctions waiver in focus
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| iShares Diversified Alternatives Trust (NASDAQ: ALT) | Delayed: 2.19 -0.01 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.20 | 52 Week High | $54.24 | |||
| Open | $2.22 | 52 Week Low | $48.35 | |||
| Day High | $2.26 | P/E | N/A | |||
| Day Low | $2.18 | EPS | $0.00 | |||
| Volume | 951,367 | |||||
